B
EXAS

Braidwell’s Exact Sciences EXAS Stock Holding History

Braidwell’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-414,600
Closed -$22.7M – 79
2025
Q3 		$22.7M Buy
+414,600
New +$20.7M 0.67% 42
2025
Q1 		– Sell
-353,000
Closed -$19.8M – 69
2024
Q4 		$19.8M Buy
353,000
+66,822
+23% +$4.16M 0.59% 50
2024
Q3 		$19.5M Sell
286,178
-855,500
-75% -$48.3M 0.55% 52
2024
Q2 		$48.2M Buy
+1,141,678
New +$62.8M 1.51% 29

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Braidwell's EXAS Position: Q4 2025 in Review

Braidwell sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 414,600 shares — an estimated $22.7M sold.

Braidwell first reported a position in EXAS in Q2 2024 and held it in 4 quarters. The position peaked at $48.2M in Q2 2024. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Braidwell reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Braidwell sold 414,600 Exact Sciences shares in Q4 2025, an estimated $22.7M.
  • Braidwell first reported a position in Exact Sciences in Q2 2024 and held it in 4 quarters.
  • Braidwell's Exact Sciences position peaked at $48.2M in Q2 2024.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Braidwell's 13F filing for Q4 2025, filed 17 Feb 2026.